IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis-Reference-Cited by-同舟云学术

IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis

Published:2021-12-20 Issue:3 Volume:130 Page:375-384
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Zhao Qi¹²^ORCID,Zheng Yanbo²^ORCID,Lv Xing³,Gong Jianhua²^ORCID,Yang Lijun¹

Affiliation:

1. Department of Pharmacology, Shanxi Medical University Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education Taiyuan China

2. Department of Oncology, Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Biochemistry and Molecular Biology, Shanxi Medical University Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education Taiyuan China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13694

Reference35 articles.

1. Pancreatic cancer

2. Pancreatic cancer